As the title implies, this final rule clarifies and amends the discount safe harbor at 42 C.F.R. § 1001.925(h) under the federal Anti-kickback statute (AKS) such that rebates paid from drug manufacturers to Medicare Part D prescription drug plan sponsors or their pharmacy benefit managers (PBMs) are not protected from liability under the discount safe harbor. The rule also adds a new safe harbor for point-of-sale reductions in price that are passed on directly to a buyer (a defined term under the rule) and an additional safe harbor for “legitimate” service fees paid to PBMs by drug manufacturers.
OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees
More Issues
Wade’s Health Law Highlights for September 8, 2026
Texas hospitals began losing $27 million a day in Medicaid funding on September 1 after CMS withheld approval of about $9.8 billion tied to…
Wade’s Health Law Highlights for September 1, 2026
The Justice Department’s National Fraud Enforcement Division named healthcare one of five enforcement priorities, singling out telemedicine, Medicare and Medicaid billing, controlled substance diversion,…
Wade’s Health Law Highlights for August 25, 2026
The Fifth Circuit, sitting en banc, vacated the federal regulations governing how insurers calculate the qualifying payment amount under the No Surprises Act. In…
